A Clinical Study With Adalimumab Biosimilar

Clinical trial NCT06291948 · COMPLETED

Trial details

NCT number: NCT06291948
Sponsor: Laboratorios Richmond S.A.C.I.F.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Safety Issues

Start date: 2022-08-01
Primary completion: 2023-01-10
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.